Last Updated: June 29, 2024
bespokecancertrials.com has 4 NS records, 2 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for bespokecancertrials.com are ns-1590.awsdns-06.co.uk, ns-201.awsdns-25.com, ns-851.awsdns-42.net, ns-1093.awsdns-08.org. A records for bespokecancertrials.com are 52.218.229.162, 52.92.148.179. We have observed bespokecancertrials.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.218.216.27 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout ASI to find another asset.
52.218.229.162
52.92.148.179
No DNS AAAA records
No DNS MX records
ns-1590.awsdns-06.co.uk
ns-201.awsdns-25.com
ns-851.awsdns-42.net
ns-1093.awsdns-08.org
No DNS TXT records
bespokecancertrials.com has 1 subdomains in our inventory.
AmazonS3
52.218.216.27
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-05-29t17:08:28+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for bespokecancertrials.com. Please check back at a later time.